Resources Contact Us Home
Enhanced bimatoprost ophthalmic solution

Image Number 2 for United States Patent #7851504.

A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein.A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein.

  Recently Added Patents
Method to quantify siRNAs, miRNAs and polymorphic miRNAs
Triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors
Process to increase selectivity to ethylene in oxygenates-to-olefins conversions
Testing SQL query writing skills
Manipulation of an alternative respiratory pathway in photo-autotrophs
Method of forming wafer level mold using glass fiber and wafer structure formed by the same
Illumination apparatus
  Randomly Featured Patents
Thermosetting coating composition comprising polymeric catalyst-II
5-(4-piperidinyl)dibenzothiazepine derivatives and 5-(4-piperidinyl)dibenzoxazepine derivatives, and antiarrhythmic agents
Displaceable feeding fence
Method for synthesis of aryl difluoromethyl ethers
Devices and methods for repairing soft tissue
Lever switch and method of operating the same
Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry
Polarization-enhanced detector with gold nanorods for detecting nanoscale rotational motion and method therefor
Tamp pad for label printer applicator
Tension chord made of hydraulically setting masses